Form
Powder
Appearance
Almostwhiteoroff-whitepowder
Source
PseudomonasFluorescens.
WaterContent(KarlFisher)
≤1.0%
pH
3.5-4.5
OpticalRotation
-17°to-21°
Assay
(OnDriedBasis):920–1020μg/mg
Mupirocinisacarboxylicacidbacteriostatic/bactericidalantibiotic.
TOKU-Eoffersthreeformsofmupirocin: mupirocin(M022), mupirocinlithiumsalt(M023),andmupirocincalcium.Mupirocinissparinglysolubleinaqueoussolutionat26.5µg/mL.Mupirocinlithiumisfreelysolubleat10mg/mL.
12650-69-0
C26H44O9
500.62
Mupirocininhibitsproteinsynthesisbybindingtoisoleucyl-tRNAsynthetase,anenzymewhichconjugatestheaminoacidisoleucinetoitscorrespondingtRNA.
2-8°C
2941.90.5000
MupirociniscommonlyusedtotargetgrampositivebacteriaespeciallyMethicillinresistantStaphylococcusaureus(MRSA).
Powder
Almostwhiteoroff-whitepowder
PseudomonasFluorescens.
≤1.0%
3.5-4.5
-17°to-21°
(OnDriedBasis):920–1020μg/mg